Oscar Health Inc. (OSCR) Tops Q2 EPS by 4c; tops guidance

Oscar Health Inc. (NYSE: OSCR) reported Q2 EPS of $0.20, $0.04 better than the analyst estimate of $0.16. Revenue for the quarter came in at $2.22 billion versus the consensus estimate of $2.21 billion.

GUIDANCE:

Oscar Health Inc. sees FY2024 revenue of $9-9.1 billion, versus the consensus of $8.6 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Zenas BioPharma (ZBIO) files for up to 7M share offering by selling stockholders
• Trilogy Metals closes $35.6M investment from U.S. Department of War